Clinical and molecular aspects of diseases of mitochondrial DNA instability

Area of Science:

• Cellular Biology
• Genetics
• Biochemistry

Background:

• Mitochondria contain circular mitochondrial DNA (mtDNA) crucial for cellular function.
• mtDNA relies on nuclear-encoded proteins for replication, transcription, and translation.
• Instability in mtDNA can originate from intrinsic mtDNA defects or secondary nuclear DNA abnormalities.

Purpose of the Study:

• To review the characteristics of mtDNA and its associated proteins.
• To emphasize the role of mitochondrial nucleoid structures in mtDNA metabolism.
• To categorize mtDNA instabilities based on molecular etiologies and link them to clinical manifestations.

Main Methods:

• Literature review of mtDNA characteristics, metabolism, and nucleoid components.
• Categorization of mtDNA instabilities based on primary mtDNA defects or secondary nuclear gene abnormalities.
• Correlation of molecular defects with clinical aspects of mitochondrial DNA diseases.

Main Results:

• Detailed introduction to mtDNA, including its replication, transcription, translation, and key proteins like POLG, Twinkle, and TFAM.
• Emphasis on mitochondrial nucleoid structure and its protein components (Twinkle, TFAM, ATAD3).
• Classification of mtDNA instabilities into primary mtDNA defects (large deletions, point mutations) and secondary nuclear defects (e.g., POLG1, Twinkle, ANT1, TK2, dGK, TP gene mutations).

Conclusions:

• mtDNA instabilities have diverse molecular origins, stemming from either mtDNA itself or nuclear DNA.
• Understanding these molecular etiologies is crucial for diagnosing and managing mitochondrial DNA diseases.
• This review provides a framework connecting molecular defects to clinical presentations, aiding medical professionals.